SEC Form D · filed January 11, 2023
INVO Bioscience, Inc
Industry
Other Health Care
Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.
People & firms on this filing (24)
Trent Davis · Sarasota, FLDirectorBarbara Ryan · Sarasota, FLDirectorSteven Shum · Sarasota, FLExec · DirectorJeffrey Segal · Sarasota, FLDirectorMichael J. Campbell · Sarasota, FLExecMatthew Szot · Sarasota, FLDirectorRebecca Messina · Sarasota, FLDirectorAndrea Goren · Sarasota, FLExecDavid E. Kass · Columbus, OHExecDavid K. Pearson · Houston, TXDirectorVictor Kuznetsov · FORT LAUDERDALE, FLExecDavid Andonian · New York, NYExec · DirectorJennifer L. Bercy · Woodland Hills, CADirectorDavid K. Hiemstra · Houston, TXDirectorEmre Altinok · Brooklyn, NYDirectorAdrian Waters · Dublin 2, IrelandDirectorBrett Paulk · Tomball, TXExec · DirectorJohn Galdieri Iii · ANNAPOLIS, MDExecPatrick Britton-Harr · ANNAPOLIS, MDDirectorWenyi Huang · Dallas, TXDirectorJon Bridgman · Toronto, Ontario, CanadaExecGuillaume Luccisano · Cambridge, MADirectorDavid M. Emery · St Peter Port, Y7DirectorRichard A. Western · Atlanta, GADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗